심전도(ECG) 기기 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Electrocardiogram Devices Market, valued at USD 7.7 billion in 2024, is expected to expand at a CAGR of 4.2% from 2025 to 2034. Cardiovascular diseases, including heart attacks, arrhythmias, and hypertension, continue to be major health challenges worldwide, driving the demand for ECG devices. These conditions are among the leading causes of death globally, highlighting the need for early detection and continuous monitoring. The aging population, which is more prone to heart-related complications, plays a significant role in boosting market growth.

Governments worldwide are prioritizing early detection and management of cardiovascular diseases, while healthcare expenditures rise to support the development of advanced medical technologies. There is also growing awareness about heart health, prompting a shift toward preventive care and regular cardiac screenings. Continuous advancements in ECG devices, such as enhanced digital connectivity and improved diagnostic algorithms, are making them increasingly accessible and effective across various healthcare settings, including hospitals, diagnostic centers, and home healthcare. This broader availability and enhanced functionality are key drivers of market expansion.

In terms of product types, the ECG devices market is primarily divided into diagnostic ECG machines and monitoring ECG devices. The diagnostic ECG machines segment is set to grow at a CAGR of 3.7%, reaching USD 6.1 billion by 2034. These machines play a crucial role in detecting cardiac abnormalities, allowing healthcare providers to assess heart activity with high precision. The increasing prevalence of chronic conditions related to aging is a significant factor driving the demand for diagnostic machines. At the same time, continuous technological improvements, such as multi-lead configurations and digital integration, are enhancing their efficiency and accuracy in clinical settings, streamlining workflows and improving patient outcomes.

When broken down by lead type, the ECG devices market is categorized into single-lead, 3-lead, 6-lead, 12-lead, and other lead types. The 12-lead ECG segment stands out, projected to grow at a CAGR of 4.7%, reaching USD 5.3 billion by 2034. This segment dominates due to its comprehensive ability to assess the heart's activity, making it indispensable for diagnosing complex cardiovascular conditions. Healthcare professionals rely heavily on 12-lead ECGs for their accuracy and detailed analysis of heart rhythms, especially in emergency and critical care settings. These devices are vital in intensive care units and cardiac monitoring centers due to their extensive diagnostic capabilities, ensuring precise monitoring of heart health.

In the United States, the ECG devices market was valued at USD 2.4 billion in 2024, with expectations to grow at a CAGR of 3.8% through 2034. The persistent high prevalence of cardiovascular diseases continues to drive the demand for ECG devices, as early diagnosis and continuous monitoring are crucial for managing heart conditions. The U.S. is also witnessing an aging population that is more susceptible to chronic heart diseases, further fueling market demand. With its robust healthcare infrastructure and ongoing technological advancements, the U.S. is well-positioned to lead the global market. As investments in innovative ECG solutions rise and patient awareness improves, the U.S. market is set for continued growth in the coming years.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of cardiovascular diseases
    • 3.2.1.2 Technological advancements in ECG devices
    • 3.2.1.3 Increasing adoption of mobile and telemetry cardiac monitors
    • 3.2.1.4 Rising awareness about heart health
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced ECG devices
    • 3.2.2.2 Lack of skilled professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Overview on usefulness of wearable ECG devices in patients experiencing paroxysmal cardiac-related symptoms
• 3.11 Development of a handheld electrocardiogram device in a clinical setting
• 3.12 Development of flexible wearable electrodes for electrocardiogram monitoring during exercise

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Diagnostics ecg machines
  • 5.2.1 Resting ecg
  • 5.2.2 Stress ecg
• 5.3 Monitoring ecg devices
  • 5.3.1 Holter monitoring
  • 5.3.2 ECG telemetry monitoring/Event monitoring
  • 5.3.3 Implantable cardiac monitors
  • 5.3.4 Other monitoring ecg devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2021 — 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Single lead type
• 6.3 3 lead type
• 6.4 6 lead type
• 6.5 12 lead type
• 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By Portability, 2021 — 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Non-portable device
• 7.3 Portable device

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Ambulatory surgical centers
• 8.4 Diagnostic centers
• 8.5 Home care settings
• 8.6 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ALIVECOR
• 10.2 Allengers
• 10.3 biotricity
• 10.4 bionet
• 10.5 BIOTRONIK
• 10.6 Boston Scientific
• 10.7 BPL Medical Technologies
• 10.8 CARDIOLINE
• 10.9 FUKUDA
• 10.10 GE HealthCare
• 10.11 Baxter
• 10.12 PHILIPS
• 10.13 Medtronic
• 10.14 mindray
• 10.15 SPACELABS HEALTHCARE